Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Vertex Pharmaceuticals (Sweden) AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 68,717 Less Arrow 58,242 Less Arrow 51,614
Financial expenses 2 More Arrow 332 Less Arrow 114
Earnings before taxes 4,907 Less Arrow 3,832 Less Arrow 3,457
EBITDA 4,985 Less Arrow 4,610 Less Arrow 3,589
Total assets 36,430 Less Arrow 32,610 More Arrow 65,540
Current assets 36,353 Less Arrow 32,342 More Arrow 64,752
Current liabilities 16,304 Less Arrow 16,250 More Arrow 52,004
Equity capital 20,126 Less Arrow 16,360 Less Arrow 13,536
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 11 Less Arrow 9 Less Arrow 7

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 55.2% Less Arrow 50.2% Less Arrow 20.7%
Turnover per employee 6,247 More Arrow 6,471 More Arrow 7,373
Profit as a percentage of turnover 7.1% Less Arrow 6.6% More Arrow 6.7%
Return on assets (ROA) 13.5% Less Arrow 12.8% Less Arrow 5.4%
Current ratio 223.0% Less Arrow 199.0% Less Arrow 124.5%
Return on equity (ROE) 24.4% Less Arrow 23.4% More Arrow 25.5%
Change turnover 10,475 Less Arrow 6,628 Less Arrow 6,491
Change turnover % 18% Less Arrow 13% More Arrow 14%
Chg. No. of employees 2 Equal arrow 2 Less Arrow 0
Chg. No. of employees % 22% More Arrow 29% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.